BRIEF-Sino Biopharmaceutical Says Lenalidomide Capsules Gets Approval Of Drug Supplementary Application

Nov 21 (Reuters) - Sino Biopharmaceutical Ltd:

* UNIT GETS NOD OF DRUG SUPPLEMENTARY APPLICATION BY NMPA OF CHINA FOR ADDITION OF 2 SPECIFICATIONS OF 5MG AND 10MG Source text for Eikon: Further company coverage: